12/4/2020  8:20:01 AM Chg. -0.1000 Volume Bid10:40:30 AM Ask10:40:30 AM Market Capitalization Dividend Y. P/E Ratio
25.6000EUR -0.39% 0
Turnover: 0.0000
25.8000Bid Size: 300 26.0000Ask Size: 300 1.03 bill.EUR 0.15% -

Business description

Biotest is a provider of plasma proteins and biotherapeutic drugs. With a value added chain that extends from pre-clinical and clinical development to worldwide sales, Biotest has specialised primarily in the areas of clinical immunology, haematology and intensive medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and haematopoietic systems. In addition Biotest develops monoclonal antibodies in the indications of rheumatoid arthritis and cancer of plasma cells, which are produced by recombinant technologies.
 

Management board & Supervisory board

CEO
-
Management board
Dr. Georg Floß, Dr. Michael Ramroth
Supervisory board
Rolf Hoffmann, Tan Yang, Jürgen Heilmann, Kerstin Birkhahn, Simone Fischer, Xiaoying Gao
 

Company data

Name: Biotest AG
Address: Landsteinerstraße 5,D-63303 Dreieich
Phone: +49-6103-801-0
Fax: +49-6103-801-150
E-mail: mail@biotest.de
Internet: www.biotest.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 6.38%
IPO date: 10/14/1987

Investor relations

Name: Dr. Monika Buttkereit
IR phone: +49-6103-801-4406
IR Fax: +49-6103-801-347
IR e-mail: investor_relations@biotest.de

Company calendar

CW 20 | 5/11/2021 General Shareholder Meeting
 

Main Shareholders

Freefloat
 
100.00%